Ligand Pharmaceuticals (LGND) Other Operating Expenses (2010 - 2026)
Ligand Pharmaceuticals (LGND) recorded Other Operating Expenses of $11.31 million in Q2 2026, down 9.1% from $12.44 million a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Other Operating Expenses (2010 - 2026) Analysis & Trends
On a TTM basis, Ligand Pharmaceuticals' Other Operating Expenses came in at $51.03 million as of Jun 30, 2026, down 22.7% year-over-year; for FY2025, it came in at $53.45 million, down 40.4% from FY2024.
- Across earlier years, Other Operating Expenses came in at $89.66 million in FY2024 and $37.6 million in FY2021.
- Quarterly Other Operating Expenses has ranged from $3.8 million in Q3 2021 to $37.65 million in Q2 2024 over the past five years.
- On a year-over-year basis, Other Operating Expenses has declined for five consecutive quarters, with growth averaging 6.0% over the last eight quarters.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 268.9% in Q2 2024, against a decline of 67.0% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.37 million (Q1 2026), $17.29 million (Q4 2025) and $11.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.31 Mn |
| Mar 31, 2026 | 11.37 Mn |
| Dec 31, 2025 | 17.29 Mn |
| Sep 30, 2025 | 11.07 Mn |
| Jun 30, 2025 | 12.44 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 22.42 Mn |
| Sep 30, 2024 | 18.52 Mn |
| Jun 30, 2024 | 37.65 Mn |
| Mar 31, 2024 | 11.07 Mn |
| Dec 31, 2023 | 9.98 Mn |
| Sep 30, 2023 | 11.72 Mn |
| Jun 30, 2023 | 10.21 Mn |
| Mar 31, 2023 | 12.26 Mn |
| Mar 31, 2022 | 13.28 Mn |
| Sep 30, 2021 | 3.80 Mn |
| Jun 30, 2021 | 34.10 Mn |
| Mar 31, 2021 | 17.01 Mn |
| Dec 31, 2020 | -600,000.00 |
| Mar 31, 2020 | 8.22 Mn |
API Access
Ligand Pharmaceuticals Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();